24 results on '"Kimby, Eva"'
Search Results
2. Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
3. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
4. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group
5. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
6. Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies
7. Immune Cell Modulations in Nordic FL Patients After Lenalidomide in the SAKK 35/10 Trial
8. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
9. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
10. 4.28 FISH on Paraffin-Embedded Tissue Samples is Feasible and of Prognostic Importance in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
11. Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
12. Advances in the Biology and Treatment of Waldenström's Macroglobulinemia: A Report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden
13. TCL1A expression delineates biological and clinical variability in B-cell lymphoma
14. Therapy for patients with follicular lymphoma
15. Strategies in the Management of Alemtuzumab-Related Side Effects
16. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia
17. Pharmacogenetics of cyclophosphamide in patients with hematological malignancies
18. Tolerability and safety of rituximab (MabThera®)
19. Uniform response criteria in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
20. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations
21. Beyond immunochemotherapy: Combinations of rituximab with cytokines interferon-α2a and granulocyte-macrophage colony stimulating factor
22. High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD
23. Promising results in MDS-AML after combination treatment with GM-CSF and chemotherapy
24. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.